RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer | Nature Communications
IJMS | Free Full-Text | Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer
Histologic Transformation in EGFR-Mutant Lung Adenocarcinomas: Mechanisms and Therapeutic Implications
Small cell lung cancer transformation: From pathogenesis to treatment - ScienceDirect
Resistant SCLCs respond to ABT-263 and lose EGFR expression. (a) The... | Download Scientific Diagram
Transformation to small cell lung cancer after first-line afatinib treatment - ScienceDirect
Oligoprogressive Disease With SCLC Transformation in EGFR-Mutated NSCLC: How Biology Knowledge Can Change the Game Rules - Journal of Thoracic Oncology
Histology transformation-mediated pathological atypism in small-cell lung cancer within the presence of chemotherapy: A case report
Choosing Therapy for NSCLC to SCLC Transformation in EGFR+ Disease
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. | Semantic Scholar
Abandoning the Notion of Non-Small Cell Lung Cancer: Trends in Molecular Medicine
Histologic Transformation From NSCLC to SCLC: A Mechanism of Resistance to Osimertinib and Other Agents Targeting EGFR Mutations - ILCN.org (ILCN/WCLC)
Non-small cell lung cancer-small cell lung cancer transformation as mechanism of resistance to tyrosine kinase inhibitors in lung cancer
Small Cell Lung Cancer Transformation: What Is It and How Do We Treat It? - GO2 for Lung Cancer
Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumors. | Semantic Scholar
Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?
Transformation to small cell lung cancer and activation of KRAS during long‑term erlotinib maintenance in a patient with non‑small cell lung cancer: A case report
Journal of Pathology and Translational Medicine
Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer | Scientific Reports
Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report
Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases | LCTT
Case presentation of small cell transformation of non-small cell lung... | Download Scientific Diagram
Small cell lung cancer transformation: From pathogenesis to treatment - ScienceDirect
Small cell lung cancer transformation during antitumor therapies: A systematic review
